Grand Central Investment Group’s AbbVie ABBV Stock Holding History

Grand Central Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.52M	Sell	6,987 -42	-0.6%	-$9.32K	1.12%	25
2025 Q4	$1.61M	Buy	+7,029	New	+$1.6M	1.17%	26
2022 Q3	$1.05M	Buy	7,849 +33	+0.4%	+$4.74K	1.47%	16
2022 Q2	$1.2M	Sell	7,816 -456	-6%	-$69.7K	1.72%	16
2022 Q1	$1.34M	Sell	8,272 -100	-1%	-$14.5K	1.59%	18
2021 Q4	$1.13M	Sell	8,372 -510	-6%	-$60.2K	1.36%	17
2021 Q3	$958K	Sell	8,882 -1,354	-13%	-$155K	1.27%	19
2021 Q2	$1.15M	Buy	10,236 +425	+4%	+$47.9K	1.03%	20
2021 Q1	$1.06M	Buy	9,811 +218	+2%	+$23.3K	1.03%	20
2020 Q4	$1.03M	Buy	+9,593	New	+$922K	0.92%	24

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Grand Central Investment Group's ABBV Position: Q1 2026 in Review

Grand Central Investment Group reduced its AbbVie (ABBV) stake by 0.6% in Q1 2026, selling an estimated $9.32K and leaving 6,987 shares worth $1.52M. The position accounts for 1.12% of the portfolio, ranked #25.

Grand Central Investment Group first reported a position in ABBV in Q4 2020 and has held it in 10 quarters since. The position peaked at $1.61M in Q4 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Grand Central Investment Group held 6,987 shares of AbbVie worth $1.52M as of Q1 2026.
Grand Central Investment Group sold 42 AbbVie shares in Q1 2026, an estimated $9.32K.
AbbVie made up 1.12% of Grand Central Investment Group's portfolio in Q1 2026, its #25 holding.
Grand Central Investment Group first reported a position in AbbVie in Q4 2020 and has held it in 10 quarters since.
Grand Central Investment Group's AbbVie position peaked at $1.61M in Q4 2025.
4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Grand Central Investment Group's 13F filing for Q1 2026, filed 23 Apr 2026.